Intra-Cellular Therapies (ITCI) Insider Trading & Ownership $85.64 +2.29 (+2.75%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Intra-Cellular Therapies (NASDAQ:ITCI) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.60%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)9Amount OfInsider Selling(Last 12 Months)$46.91 M Get ITCI Insider Trade Alerts Want to know when executives and insiders are buying or selling Intra-Cellular Therapies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ITCI Insider Buying and Selling by Quarter Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Intra-Cellular Therapies Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/12/2024Michael HalsteadPresidentSell22,869$89.12$2,038,085.28 8/30/2024Sharon MatesCEOSell34,396$72.84$2,505,404.64 8/27/2024Sharon MatesCEOSell40,513$73.58$2,980,946.54 8/23/2024Sharon MatesCEOSell28,680$74.46$2,135,512.80 8/21/2024Sharon MatesCEOSell53,013$75.65$4,010,433.45 8/16/2024Mark NeumannEVPSell18,714$75.08$1,405,047.12 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/24/2024Rory B RiggsDirectorSell4,462$75.57$337,193.34 6/21/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$76.58$1,001 - $15,0006/18/2024Nostrand Robert L VanDirectorSell20,000$75.91$1,518,200.00 3/11/2024Lawrence J. HinelineCFOSell10,121$65.96$667,581.16 3/11/2024Michael HalsteadEVPSell7,345$65.97$484,549.65 3/11/2024Sharon MatesCEOSell20,565$65.21$1,341,043.65 3/7/2024Lawrence J. HinelineCFOSell13,132$66.60$874,591.20 3/7/2024Sharon MatesCEOSell40,712$66.50$2,707,348.00 3/7/2024Suresh K DurgamEVPSell6,450$66.56$429,312.00 2/26/2024Joel S MarcusDirectorSell26,328$68.68$1,808,207.04 2/26/2024Lawrence J. HinelineCFOSell13,337$69.43$925,987.91 2/26/2024Michael HalsteadEVPSell7,907$69.53$549,773.71 2/26/2024Sharon MatesCEOSell22,590$69.79$1,576,556.10 1/18/2024Sharon MatesCEOSell67,917$65.19$4,427,509.23 1/16/2024Sharon MatesCEOSell75,361$67.25$5,068,027.25 1/11/2024Michael HalsteadEVPSell50,000$66.83$3,341,500.00 1/2/2024Suresh K. DurgamEVPSell62,282$70.60$4,397,109.20 12/13/2023Suresh K. DurgamEVPSell21,262$65.00$1,382,030.00 (Data available from 1/1/2013 forward) ITCI Insider Trading Activity - Frequently Asked Questions Who is on Intra-Cellular Therapies's Insider Roster? The list of insiders at Intra-Cellular Therapies includes Joel S Marcus, Lawrence J Hineline, Mark Neumann, Michael Halstead, Nostrand Robert L Van, Rory B Riggs, Sharon Mates, Suresh K Durgam. Learn more on insiders at ITCI. What percentage of Intra-Cellular Therapies stock is owned by insiders? 2.60% of Intra-Cellular Therapies stock is owned by insiders. Learn more on ITCI's insider holdings. Which Intra-Cellular Therapies insiders have been selling company stock? The following insiders have sold ITCI shares in the last 24 months: Joel S Marcus ($2,062,307.04), Lawrence J. Hineline ($12,158,384.04), Mark Neumann ($8,968,481.86), Michael Halstead ($9,100,408.64), Nostrand Robert L Van ($2,148,200.00), Rory B Riggs ($337,193.34), Sharon Mates ($36,654,828.17), and Suresh K Durgam ($1,643,805.96). How much insider selling is happening at Intra-Cellular Therapies? Insiders have sold a total of 1,271,842 Intra-Cellular Therapies shares in the last 24 months for a total of $78,852,748.25 sold. Which members of congress are trading Intra-Cellular Therapies? Josh Gottheimer (D-NJ) has sold shares of Intra-Cellular Therapies in the last year totaling $8,000. Intra-Cellular Therapies Key ExecutivesDr. Sharon Mates Ph.D. (Age 71)Co-Founder, Chairman & CEO Compensation: $2.23MMr. Michael I. Halstead J.D. (Age 51)President Compensation: $983.65k1 recent tradesDr. Suresh K. Durgam M.D. (Age 55)Executive VP & Chief Medical Officer Compensation: $961.84kMr. Mark Neumann (Age 61)EVP & Chief Commercial Officer Compensation: $998.36k1 recent tradesDr. Robert E. Davis Ph.D. (Age 73)Senior VP & Chief Scientific Officer Compensation: $646.12kMr. Juan Fernando Sanchez (Age 53)Vice President of Corporate Communications & Investor Relations Compensation: $296.75kMs. Karen Patruno Sheehy Esq. (Age 62)Senior VP & Chief Compliance Officer Dr. Michael OlchaskeySenior VP & Head of Regulatory AffairsMr. John A. BardiSenior VP of Market Access, Policy & Government AffairsDr. Willie R. Earley M.D.Senior VP & Head of Clinical Development More Insider Trading Tools from MarketBeat Related Companies Kura Oncology Insider Transactions Zymeworks Insider Transactions Ironwood Pharmaceuticals Insider Transactions IGM Biosciences Insider Transactions Cryoport Insider Transactions Zentalis Pharmaceuticals Insider Transactions Prelude Therapeutics Insider Transactions BioNTech Insider Transactions Teva Pharmaceutical Industries Insider Transactions BeiGene Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:ITCI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intra-Cellular Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intra-Cellular Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
